Seniors

As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo

SHELTON, CT / ACCESS Newswire / July 6, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...

BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity

Certification validates the complete day-and-night neuro-performance and repair system, positioning the company for broader adoption across elite sports and high-value...

Frost & Sullivan: Aileen.ai Receives the 2026 North American Transformational Innovation Leadership Recognition for Advancing Relationship-Based AI-Enabled Senior Care

The company's innovative AI health companion enhances continuity of care through scalable, relationship-based support for older adultsSAN ANTONIO, June 24,...

error: Content is protected !!